Strides Arcolab gets Heath Canada approval for Tobramycin Injection

02 Apr 2012 Evaluate

Strides Arcolab has received approval from Health Canada for Tobramycin Injection USP 40 mg / mL, Liquid dosage form. Tobramycin is in a group of antibiotics called aminoglycosides used to treat bacterial infections of the skin, heart, stomach, brain and spinal cord, respiratory system, and urinary tract. It is also used in the treatment of cystic fibrosis. Tobramycin injection is sometimes used together with other antibiotics.

The approval was granted under the expedited review process being adopted by Health Canada to address the severe drug shortage situation in Canada. In March 2012, Canadian Health Ministry had indicated that Health Canada will approve suppliers within a month to ease the drug shortage in Canada.

The market value of the product is approximately $4.2 million. The product will be commercialized in Q2 of 2012 directly by Strides Canadian subsidiary.

Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterile injectables. 

Strides Pharma Scien Share Price

677.80 -6.50 (-0.95%)
23-Dec-2024 09:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.95
Dr. Reddys Lab 1341.15
Cipla 1468.10
Lupin 2135.85
Zydus Lifesciences 966.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.